Literature DB >> 27268057

Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.

Masato Abe1, Yui Hasegawa1, Masahide Oku1, Yoshiki Sawada1, Eriko Tanaka1, Yasuyoshi Sakai1, Hideto Miyoshi2.   

Abstract

Remodeling of the acyl chains of cardiolipin (CL) is responsible for final molecular composition of mature CL after de novo CL synthesis in mitochondria. Yeast Saccharomyces cerevisiae undergoes tafazzin-mediated CL remodeling, in which tafazzin serves as a transacylase from phospholipids to monolyso-CL (MLCL). In light of the diversity of the acyl compositions of mature CL between different organisms, the mechanism underlying tafazzin-mediated transacylation remains to be elucidated. We investigated the mechanism responsible for transacylation using purified S. cerevisiae tafazzin with liposomes composed of various sets of acyl donors and acceptors. The results revealed that tafazzin efficiently catalyzes transacylation in liposomal membranes with highly ordered lipid bilayer structure. Tafazzin elicited unique acyl chain specificity against phosphatidylcholine (PC) as follows: linoleoyl (18:2) > oleoyl (18:1) = palmitoleoyl (16:1) ≫ palmitoyl (16:0). In these reactions, tafazzin selectively removed the sn-2 acyl chain of PC and transferred it into the sn-1 and sn-2 positions of MLCL isomers at equivalent rates. We demonstrated for the first time that MLCL and dilyso-CL have inherent abilities to function as an acyl donor to monolyso-PC and acyl acceptor from PC, respectively. Furthermore, a Barth syndrome-associated tafazzin mutant (H77Q) was shown to completely lack the catalytic activity in our assay. It is difficult to reconcile the present results with the so-called thermodynamic remodeling hypothesis, which premises that tafazzin reacylates MLCL by unsaturated acyl chains only in disordered non-bilayer lipid domain. The acyl specificity of tafazzin may be one of the factors that determine the acyl composition of mature CL in S. cerevisiae mitochondria.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  acyltransferase; cardiolipin; lysophospholipid; mitochondria; phospholipid; remodeling; tafazzin

Mesh:

Substances:

Year:  2016        PMID: 27268057      PMCID: PMC4957036          DOI: 10.1074/jbc.M116.718510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.

Authors:  Zhiming Gu; Fredoen Valianpour; Shuliang Chen; Frederic M Vaz; Gertjan A Hakkaart; Ronald J A Wanders; Miriam L Greenberg
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

2.  Characterization and regulation of phosphatidylglycerolphosphate phosphatase in Saccharomyces cerevisiae.

Authors:  B L Kelly; M L Greenberg
Journal:  Biochim Biophys Acta       Date:  1990-09-18

3.  YDL142c encodes cardiolipin synthase (Cls1p) and is non-essential for aerobic growth of Saccharomyces cerevisiae.

Authors:  G Tuller; C Hrastnik; G Achleitner; U Schiefthaler; F Klein; G Daum
Journal:  FEBS Lett       Date:  1998-01-02       Impact factor: 4.124

4.  A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4.

Authors:  Christof Osman; Mathias Haag; Felix T Wieland; Britta Brügger; Thomas Langer
Journal:  EMBO J       Date:  2010-05-18       Impact factor: 11.598

5.  Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.

Authors:  Fredoen Valianpour; Voula Mitsakos; Dimitri Schlemmer; Jeffrey A Towbin; Juliet M Taylor; Paul G Ekert; David R Thorburn; Arnold Munnich; Ronald J A Wanders; Peter G Barth; Frédéric M Vaz
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

6.  Separation and characterization of cardiolipin molecular species by reverse-phase ion pair high-performance liquid chromatography-mass spectrometry.

Authors:  Paul E Minkler; Charles L Hoppel
Journal:  J Lipid Res       Date:  2009-10-30       Impact factor: 5.922

7.  A new synthesis of lysophosphatidylcholines and related derivatives. Use of p-toluenesulfonate for hydroxyl group protection.

Authors:  Renato Rosseto; Niloufar Bibak; Rosemarie DeOcampo; Trishul Shah; Ara Gabrielian; Joseph Hajdu
Journal:  J Org Chem       Date:  2007-02-07       Impact factor: 4.354

8.  Reversibility of the binding of cytochrome c to liposomes. Implications for lipid-protein interactions.

Authors:  M Rytömaa; P K Kinnunen
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

Review 9.  Making heads or tails of phospholipids in mitochondria.

Authors:  Christof Osman; Dennis R Voelker; Thomas Langer
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

10.  A novel X-linked gene, G4.5. is responsible for Barth syndrome.

Authors:  S Bione; P D'Adamo; E Maestrini; A K Gedeon; P A Bolhuis; D Toniolo
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more
  12 in total

Review 1.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

Review 2.  Biosynthesis, remodeling and turnover of mitochondrial cardiolipin.

Authors:  Michael Schlame; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-08-21       Impact factor: 4.698

3.  Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.

Authors:  Edgard M Mejia; Hana Zegallai; Eric D Bouchard; Versha Banerji; Amir Ravandi; Grant M Hatch
Journal:  J Biol Chem       Date:  2018-03-21       Impact factor: 5.157

4.  The Basis for Acyl Specificity in the Tafazzin Reaction.

Authors:  Michael Schlame; Yang Xu; Mindong Ren
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

5.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

6.  Oversized ubiquinones as molecular probes for structural dynamics of the ubiquinone reaction site in mitochondrial respiratory complex I.

Authors:  Shinpei Uno; Takahiro Masuya; Kyoko Shinzawa-Itoh; Jonathan Lasham; Outi Haapanen; Tomoo Shiba; Daniel Ken Inaoka; Vivek Sharma; Masatoshi Murai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

Review 7.  The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

Authors:  Michael Schlame; Yang Xu
Journal:  J Mol Biol       Date:  2020-03-29       Impact factor: 5.469

Review 8.  Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.

Authors:  Anna L Duncan
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

Review 9.  Role of Tafazzin in Mitochondrial Function, Development and Disease.

Authors:  Michael T Chin; Simon J Conway
Journal:  J Dev Biol       Date:  2020-05-23

10.  Plasmalogen loss caused by remodeling deficiency in mitochondria.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Vernon Monteiro; Yang Xu; Bob Berno; Michael Schlame; Richard M Epand
Journal:  Life Sci Alliance       Date:  2019-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.